Study of treatment outcomes of multidrug-resistant tuberculosis under programmatic conditions and factors influencing the outcomes in Hyderabad District |
| |
Authors: | Subhakar Kandi Tilak Kumar K Shravika Reddy Kandi Neeta Mathur Challa Devi D Rajesham Adepu |
| |
Affiliation: | 1. Department of Respiratory Medicine, Kamineni Academy of Medical Sciences & Research Centre, Hyderabad, Telangana, India;2. Department of Respiratory Medicine, Government General & Chest Hospital, Osmania Medical College, Hyderabad, Telangana, India;3. Mallareddy Institute of Medical Sciences, Hyderabad, Telangana, India;4. Department of Community Medicine, Apollo Institute of Medical Sciences and Research, Hyderabad, Telangana, India;5. District TB Control Officer, Hyderabad, Telangana, India;6. Joint Director of Tuberculosis, Hyderabad, Telangana, India |
| |
Abstract: | BackgroundTreatment outcomes for Multidrug-Resistant Tuberculosis (MDR TB) is generally poor. The study aims to know about the treatment outcomes of MDR-TB under programmatic conditions in Hyderabad District and to analyze the factors influencing the treatment outcomes.MethodsThis is a retrospective study in which 377 patients of Hyderabad district, Telangana state who were diagnosed with MDR TB and registered at Drug Resistance TB Treatment site of Government General & Chest Hospital, Hyderabad from 4th quarter 2008 to 4th quarter 2013 were included in the study. Impact of Demographic factors (age, sex; Nutritional status (BMI); Co-morbid condition (Diabetes, HIV, Hypothyroidism); Programmatic factors (time delay in the initiation of treatment); Initial Resistance pattern on the outcomes were studied and analyzed.ResultsThe treatment outcomes of Multidrug-Resistant Tuberculosis under Programmatic Conditions were: 57% cured, 21.8% died, 19.6% defaulted, 1.1% failed and 0.5% switched to XDR. Age, Sex, BMI had a statistically significant impact on treatment outcomes. Hypothyroidism and Delay in the initiation of treatment >1 a month had an impact on the outcomes though not statistically significant. NO impact on treatment outcomes was found when Rifampicin resistance & INH sensitive patients were compared with those resistant to both INH and Rifampicin.ConclusionTo reduce MDR-TB transmission in the community, improvement of treatment outcomes, via ensuring adherence, paying special attention to elderly patients is required. The Programmatic Management of Drug Resistance Tuberculosis (PMDT) should seriously think of providing Nutritional support to patients with low BMI to improve outcomes. In the programmatic conditions if we could address the problems like delay in initiation of treatment and proper management of comorbidities like HIV, Diabetes, Hypothyroidism would definitely improve the treatment outcomes. |
| |
Keywords: | Favourable outcome Multidrug-resistant tuberculosis (MDR TB) Unfavourable outcome PMDT (Programmatic management of drug-resistant tuberculosis) |
本文献已被 ScienceDirect 等数据库收录! |
|